Potentiation of the 5-aminolevulinic acid-based photodynamic therapy with cyclophosphamide

Cancer Biochemistry Biophysics

Volumn 16, Issue 1, 1997, Pages 183-196

  Casas, Adriana ^a   Fukuda, Haydee ^a   Batlle, Alcira M Del C ^a,b  

^a Pabellón II ^*  (Argentina)

^b UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

5 aminolevulinic acid; Cyclophosphamide; Photodynamic therapy

Indexed keywords

ALKYLATING AGENT; AMINOLEVULINIC ACID; CYCLOPHOSPHAMIDE; PHOTOSENSITIZING AGENT; PORPHYRIN;

ADENOCARCINOMA; ANIMAL; ARTICLE; BAGG ALBINO MOUSE; BIOSYNTHESIS; CHEMISTRY; EXPERIMENTAL NEOPLASM; LIVER; MALE; METABOLISM; MOUSE; MULTIMODALITY CANCER THERAPY; PHOTOCHEMOTHERAPY; TIME; TISSUE DISTRIBUTION;

ADENOCARCINOMA; AMINOLEVULINIC ACID; ANIMALS; ANTINEOPLASTIC AGENTS, ALKYLATING; COMBINED MODALITY THERAPY; CYCLOPHOSPHAMIDE; LIVER; MALE; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, INBRED BALB C; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PORPHYRINS; TIME FACTORS; TISSUE DISTRIBUTION;

EID: 0343341094     PISSN: 03057232     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Cairnduff F., M. R. Stringer, E. J. Hudson, D. V. Ash and S. B. Brown (1994) Superficial photodynamic therapy with topical 5-aminolaevulinic acid for superficial primary and secondary skin cancer, Br. J. Cancer, 69, 605-608.
2. Cowled P. A., L. Mackenzie and I. J. Forbes (1987) Pharmacological modulation of photodynamic therapy with hematoporphyrin derivative and light. Cancer Res., 47, 971-974.
3. Dougherty T. J., W. R. Potter and D. Belliner (1990) Photodynamic therapy for for the treatment of cancer, current status and advances. In, D. Kessel (Ed.) Photodynamic Therapy of neoplastic disease, CRC Press, Boca Raton, FL pp 1-19.
4. Falk J. (1964) In Porphyrins and metalloporphyrins, Biochim. Biophys. Acta Library, Vol. 2 Elsevier Publishing Company, Amsterdam. London, New York.
5. Fukuda H., S. Paredes and A. M. del C. Batlle (1989) Tumor-localizing properties of porphyrins. In vitro studies using the porphyrin precursor, aminolevulinic acid, in free and liposome encapsulated forms. Drug Des. Deliv., 5, 133-139.
6. Fukuda H., S. Paredes, A. Casas, F. Chueke and A. M. del C. Batlle (1992a) Potential of liposome-entrapped aminolevulinic acid in cancer therapy. Effect of prior injection of empty liposomes and different routes of administration. Cancer J., 5, 295-299.
7. Fukuda H., S. Paredes and A. M. del C. Batlle (1992b) Tumor-localizing properties of porphyrins. In vivo studies using free and liposome encapsulated aminolevulinic acid. Comp. Biochem. Physiol., 2, 433-436.
8. Fukuda H., A. Casas, F. Chueke, S. Paredes and A. Batlle (1993) Photodynamic action of endogenously synthesized porphyrins from aminolevulinic acid, using a new model for assaying the effectiveness of tumoral cell killing. Int. J. Biochem., 25, 1395-1398.
9. Jin M. L., B. Q. Yang, W. Zhang and P. Ren (1992) Combined treatment of photodynamic therapy and chemotherapy for advanced cardiac cancers. J. Photochem, Photobiol. B. Biol., 12, 101-106.
10. Kelly J. F. and M. E. Snell (1976) Hematoporphyrin derivative: a possible aid in the diagnosis and therapy of carcinoma of the bladder. J. Urol , 115, 150-157,
11. Lipson R. L., E. J. Baldes and A. M. Olsen (1965) The use of a derivative of hematoporphyrin in tumor detection. J. Natl. Cancer Inst., 26, 1-11.
12. Ma L. W., J. Moan, H. B. Steen and V. Iani (1995) Anti-tumour activity of photodynamic therapy in combination with mitomycin C in nude mice with human colon adenocarcinoma. Br. J. Cancer, 71, 950-956.
13. Malik Z. and H. Lugaci (1987) Destruction of erythroleukaemic cells by photoactivation of endogenous porphyrins. Br. J. Cancer, 56, 589-595.
14. Nahabedian M. Y., R. A. Cohen, M. F. Contino, T. M. Terem, W. H. Wright, M. W. Berns and A. G. Wile (1988) Combination cytotoxic chemotherapy with cisplatin or doxorubicin and photodynamic therapy in murine tumors. J. Natl. Cancer Inst., 80, 739-743.
15. Palma-Carlos A. G , M. L. Palma-Carlos, M. G. Lourenco and J. A. Martins-Silva (1971) Effect of alkylating agents on haem metabolism. S. Afr. J. Lab, Clin. Med., 25, 81-84.
16. Regula J., B. Ravi, J. Bedwell, A. J. MacRobert and S. G. Bown (1994) Photodynamic therapy using 5-aminolaevulinic acid for experimental pancreatic cancer - prolonged animal survival. Br. J. Cancer, 70, 248-254.
17. Rizzardini M., D. Ferraroli, D. Dal Fiume and L. Cantoni (1984) Cyclophosphamide-impaired regulation of hepatic heme metabolism. Experientia, 40, 1390-1392.
18. Vázquez E., S. Afonso, A. M. Buzaleh, N. Navone, C. Polo, E. Schoua and A. Batlle (1987) The effect of griseofulvin on the heme pathway Studies on tissue explant cultures. Toxicology, 46, 73-82.
19. Wainstok R. and L. San Martin de Viale (1988) Effect of some antineoplasics on metabolic heme pathway. Int. J. Biochem., 20, 1015-1020.